Treasurer of the State of North Carolina Increases Holdings in Masimo Co. (NASDAQ:MASI)

Treasurer of the State of North Carolina increased its stake in Masimo Co. (NASDAQ:MASIFree Report) by 0.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,139 shares of the medical equipment provider’s stock after acquiring an additional 180 shares during the period. Treasurer of the State of North Carolina’s holdings in Masimo were worth $2,243,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in MASI. Byrne Asset Management LLC bought a new stake in shares of Masimo in the 4th quarter valued at approximately $28,000. Massmutual Trust Co. FSB ADV lifted its position in Masimo by 140.6% in the fourth quarter. Massmutual Trust Co. FSB ADV now owns 243 shares of the medical equipment provider’s stock worth $28,000 after buying an additional 142 shares during the last quarter. EverSource Wealth Advisors LLC lifted its position in Masimo by 851.6% in the fourth quarter. EverSource Wealth Advisors LLC now owns 295 shares of the medical equipment provider’s stock worth $35,000 after buying an additional 264 shares during the last quarter. Harel Insurance Investments & Financial Services Ltd. purchased a new position in Masimo during the fourth quarter worth $36,000. Finally, NBC Securities Inc. bought a new position in Masimo during the third quarter valued at $34,000. Hedge funds and other institutional investors own 85.96% of the company’s stock.

Masimo Stock Up 0.1 %

Shares of NASDAQ MASI opened at $124.80 on Friday. Masimo Co. has a 52-week low of $75.22 and a 52-week high of $167.33. The firm has a market capitalization of $6.63 billion, a price-to-earnings ratio of 84.90 and a beta of 1.00. The stock has a 50 day moving average price of $132.17 and a 200 day moving average price of $125.19. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.31 and a current ratio of 2.31.

Masimo (NASDAQ:MASIGet Free Report) last issued its earnings results on Tuesday, May 7th. The medical equipment provider reported $0.77 earnings per share for the quarter, topping the consensus estimate of $0.71 by $0.06. The business had revenue of $492.80 million during the quarter, compared to analysts’ expectations of $487.70 million. Masimo had a return on equity of 13.26% and a net margin of 4.01%. The business’s revenue for the quarter was down 12.8% compared to the same quarter last year. During the same period in the prior year, the business earned $0.87 EPS. Sell-side analysts expect that Masimo Co. will post 3.63 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on MASI shares. StockNews.com upgraded shares of Masimo from a “sell” rating to a “hold” rating in a report on Friday, March 29th. Needham & Company LLC reissued a “hold” rating on shares of Masimo in a research note on Wednesday, May 8th. Wells Fargo & Company raised Masimo from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $117.00 to $160.00 in a research note on Monday, March 25th. Stifel Nicolaus raised Masimo from a “hold” rating to a “buy” rating and raised their price target for the stock from $148.00 to $170.00 in a research note on Monday, April 15th. Finally, Piper Sandler raised Masimo from a “neutral” rating to an “overweight” rating and upped their price objective for the company from $126.00 to $160.00 in a research report on Monday. Four analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $143.57.

Read Our Latest Analysis on MASI

Insider Buying and Selling at Masimo

In other news, Director Craig B. Reynolds sold 40,000 shares of the company’s stock in a transaction that occurred on Friday, April 26th. The shares were sold at an average price of $136.17, for a total value of $5,446,800.00. Following the completion of the sale, the director now owns 7,406 shares of the company’s stock, valued at approximately $1,008,475.02. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 9.70% of the company’s stock.

About Masimo

(Free Report)

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.

See Also

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASIFree Report).

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.